Remove 2024 Remove AFIB Remove Atrial Fibrillation
article thumbnail

New Data Available for Minimally Invasive Treatment of AFib

DAIC

tim.hodson Tue, 11/19/2024 - 15:57 Nov. 18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to treat people with atrial fibrillation (AFib) who are at an increased risk of stroke. 16-18, 2024).

AFIB 52
article thumbnail

Study Shows Medtronic ICM Accurately Predicts Risk Thresholds for AFib Patients Using AI

DAIC

16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrial fibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time.

AFIB 52
article thumbnail

HRS 2024: Innovation Meets Reality

DAIC

PFA is designed to address AFib, the most common arrhythmia in the US, with a growing patient population. Antiarrhythmic drugs are typically a poor solution for AFib, as their side effects can be debilitating. The operational and safety benefits are “nice,” but AFib ablation has never really been a dangerous procedure.

article thumbnail

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

DAIC

mtaschetta-millane Tue, 07/16/2024 - 09:47 July 16, 2024 — Ultrahuman, a pioneer in wearable technology , launches PowerPlugs, a platform for individual apps and plugins built on top of Ultrahuman’s health and wellness data stack. Ultrahuman Ring AIR is the first smart ring in the world to offer AFib detection.

AFIB 105
article thumbnail

Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow (EGF) Mapping for use in Atrial Fibrillation Ablation

DAIC

Getty Images milla1cf Tue, 02/06/2024 - 20:36 February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial ( NCT05883631 ), a study formally launched in late October 2023. AFib is the most common heart rhythm disorder, affecting more than 30 million patients worldwide.

Ablation 104
article thumbnail

Study Shows Abelacimab Significantly Reduced Bleeding vs. Standard DOAC

DAIC

Affecting 60 million people worldwide 1 , the prevalence of atrial fibrillation (AFib) is expected to increase by 60% by 2050 due to an aging population and rising cardiometabolic risk factors 2. Today, 40% to 60% of patients with AFib are either not prescribed anticoagulants or are undertreated 4. Patel SM, Ruff CT.

AFIB 52
article thumbnail

PFA Shows Promise in Reducing AA Burden in AFib

American College of Cardiology

Pulsed field ablation (PFA) was shown to be effective in treating patients with paroxysmal atrial fibrillation (AFib), with more patients free from atrial arrhythmias (AA) when compared with patients treated with thermal ablation, according to results from a secondary analysis of the ADVENT trial.

AFIB 55